Bayer is reportedly thinking of buying Monsanto for 40 billion dollars. If it goes through, it promises to be a controversial buy for the German company.
Pharma giant Bayer will sell some assets to its German rival BASF to gain regulatory approval for its takeover of US firm Monsanto, and create a company that will control more than a quarter of the world seed's market.
Genetically modified food has never enjoyed the best reputation. Such is the depth of opposition to GM, even ideas that seem to promise a better future have been viewed with the utmost suspicion.
The EU Commission has announced it's opened an in-depth investigation into the mega takeover of Monsanto by Germany’s Bayer. Brussels said competition concerns had not been addressed sufficiently.
At Bayer's annual general meeting in Bonn, environmentalists and politicians voiced discontent over the proposed takeover. Both companies have come under fire for substandard ethical and environmental practices.
© 2018 Deutsche Welle |
Legal notice |
| Mobile version